Invasc Therapeutics -Developing first-in-class drugs for the cardiometabolic market
Invasc Therapeutics -Developing first-in-class drugs for the cardiometabolic market
  • Home
  • Products
    • INV - 144
    • INV-404 / INV-405
    • INV-155
    • INV-311
  • Cardiometabolic Diseases
    • Chronic Kidney Failure
    • Insulin Resistance
    • Hypertension
    • Atherosclerosis
    • Oxidative Tissue Damage
  • Investor Relations
    • Strategic Partners
  • News
  • About Us
    • Executive Team
    • Board of Directors
    • Scientific Advisory Board
  • Contact us
    • Corporate Information
    • Directions

Copyright © 2010 InVasc Therapeutics, Inc. All rights reserved.                                                                                            Privacy Policy | Terms of use